| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| Keti Bardhi, Christy Watson, Gang Chen, Philip Lazaru. Inhibitory Effects of Major Cannabinoids and their Metabolites on Oxazepam Metabolism. FASEB journal : official publication of the Federation of American Societies for Experimental Biology. vol 36 Suppl 1. 2022-05-14. PMID:35567461. |
cannabis and cannabis-derived products are increasingly used for recreational and medical purposes including anxiety and epilepsy and are often concurrently used with other types of conventional medications. |
2022-05-14 |
2023-08-13 |
Not clear |
| Jessica L Beers, Aurora Authement, Nina Isoherranen, Klarissa D Jackso. Formation of the Major Circulating Metabolite of Cannabidiol by Non-P450, Cytosolic Enzymes. FASEB journal : official publication of the Federation of American Societies for Experimental Biology. vol 36 Suppl 1. 2022-05-13. PMID:35554668. |
cannabidiol (cbd), a natural product derived from cannabis, was recently fda-approved to treat epilepsy in children. |
2022-05-13 |
2023-08-13 |
human |
| Stephanie Hui Kit Yap, Jieming Pan, Dao Viet Linh, Xiangyu Zhang, Xinghua Wang, Wei Zhe Teo, Evgeny Zamburg, Chen-Khong Tham, Wen Shan Yew, Chueh Loo Poh, Aaron Voon-Yew Thea. Engineered Nucleotide Chemicapacitive Microsensor Array Augmented with Physics-Guided Machine Learning for High-Throughput Screening of Cannabidiol. Small (Weinheim an der Bergstrasse, Germany). 2022-05-06. PMID:35521934. |
the recent legalization of cannabidiol (cbd) to treat neurological conditions such as epilepsy has sparked rising interest across global pharmaceuticals and synthetic biology industries to engineer microbes for sustainable synthetic production of medicinal cbd. |
2022-05-06 |
2023-08-13 |
Not clear |
| Megan Malach, Igor Kovalchuk, Olga Kovalchu. Medical Cannabis in Pediatric Oncology: Friend or Foe? Pharmaceuticals (Basel, Switzerland). vol 15. issue 3. 2022-03-26. PMID:35337156. |
however, there exist many published cases of use of cannabis in children to treat pediatric epilepsy and chemotherapy-induced nausea and vomiting (cinv) that show both the safety and efficacy of cannabis in pediatric populations. |
2022-03-26 |
2023-08-13 |
Not clear |
| Orrin Devinsky, Angelica Marmanillo, Theresa Hamlin, Philip Wilken, Daniel Ryan, Conor Anderson, Daniel Friedman, George Tod. Observational study of medical marijuana as a treatment for treatment-resistant epilepsies. Annals of clinical and translational neurology. 2022-03-10. PMID:35267245. |
observational study of medical marijuana as a treatment for treatment-resistant epilepsies. |
2022-03-10 |
2023-08-13 |
Not clear |
| Orrin Devinsky, Angelica Marmanillo, Theresa Hamlin, Philip Wilken, Daniel Ryan, Conor Anderson, Daniel Friedman, George Tod. Observational study of medical marijuana as a treatment for treatment-resistant epilepsies. Annals of clinical and translational neurology. 2022-03-10. PMID:35267245. |
medical cannabis formulations with cannabidiol (cbd) and delta-9-tetrahydrocannabinol (thc) are widely used to treat epilepsy. |
2022-03-10 |
2023-08-13 |
Not clear |
| John Lawson, Terry O'Brien, Myfanwy Graham, Elianne Renaud, Dean Jones, Jeremy Freeman, Nicholas Lawn, Jennifer H Marti. Expert advice for prescribing cannabis medicines for patients with epilepsy-drawn from the Australian clinical experience. British journal of clinical pharmacology. 2022-03-09. PMID:35261078. |
to address the unmet need in epilepsy, and until medicines were registered or regulator quality data were available, it was agreed to bring together a working group comprising paediatric and adult epilepsy specialists, clinical pharmacists., clinical pharmacologists and cannabis researchers from across australia to develop interim consensus advice for prescribers. |
2022-03-09 |
2023-08-13 |
Not clear |
| John Lawson, Terry O'Brien, Myfanwy Graham, Elianne Renaud, Dean Jones, Jeremy Freeman, Nicholas Lawn, Jennifer H Marti. Expert advice for prescribing cannabis medicines for patients with epilepsy-drawn from the Australian clinical experience. British journal of clinical pharmacology. 2022-03-09. PMID:35261078. |
although interim, this consensus advice addresses much of the current practice gap by providing an informed overview of the different cannabis medicines currently available for use in the treatment of epilepsy in paediatric and adult settings, with information on dose, drug interactions, toxicity, type of seizure and frequency of symptom relief. |
2022-03-09 |
2023-08-13 |
Not clear |
| Nilma R L L Janisset, Simone A A Romariz, Debora Hashiguchi, Miguel L Quintella, Christiane Gimenes, Thais Yokoyama, Renato Filev, Elisaldo Carlini, Regina Barbosa da Silva, Jean Faber, Beatriz M Long. Partial protective effects of cannabidiol against PTZ-induced acute seizures in female rats during the proestrus-estrus transition. Epilepsy & behavior : E&B. vol 129. 2022-02-26. PMID:35217387. |
cannabidiol (cbd) has been proposed to have anticonvulsant and anti-inflammatory effects, able to decrease seizure duration and increase seizure threshold in rats with epilepsy. |
2022-02-26 |
2023-08-13 |
rat |
| Maria Mazurkiewicz-Bełdzińska, Marta Zawadzk. Use of cannabidiol in the treatment of epilepsy. Neurologia i neurochirurgia polska. 2022-02-25. PMID:35211946. |
use of cannabidiol in the treatment of epilepsy. |
2022-02-25 |
2023-08-13 |
human |
| Maria Mazurkiewicz-Bełdzińska, Marta Zawadzk. Use of cannabidiol in the treatment of epilepsy. Neurologia i neurochirurgia polska. 2022-02-25. PMID:35211946. |
cannabis sativa has been cultivated for human use for about 5,000 years, and has likewise been used in the treatment of epilepsy for thousands of years. |
2022-02-25 |
2023-08-13 |
human |
| Joyce Y Wu, Hannah R Cock, Orrin Devinsky, Charuta Joshi, Ian Miller, Colin M Roberts, Rocio Sanchez-Carpintero, Daniel Checketts, Farhad Sahebka. Time to Onset of Cannabidiol (CBD) Treatment Effect and Resolution of Adverse Events in Tuberous Sclerosis Complex: Post Hoc Analysis of Randomized Controlled Phase 3 Trial GWPCARE6. Epilepsia. 2022-02-17. PMID:35175622. |
to estimate the timing of cannabidiol (cbd) treatment effect (seizure reduction and adverse events [aes]) onset, we conducted a post hoc analysis of gwpcare6 (nct02544763), a randomized, placebo-controlled, phase 3 trial in patients with drug-resistant epilepsy associated with tuberous sclerosis complex (tsc). |
2022-02-17 |
2023-08-13 |
Not clear |
| Lindsey Shapiro, Andrew Escayg, Jennifer C Won. Cannabidiol Increases Seizure Resistance and Improves Behavior in an Frontiers in pharmacology. vol 13. 2022-02-14. PMID:35153788. |
cannabidiol increases seizure resistance and improves behavior in an voltage-gated sodium channel genes are an important family of human epilepsy genes. |
2022-02-14 |
2023-08-13 |
human |
| S Harte, Y Singh, S Malone, H Heussler, G Wallac. Cannabidiol and refractory epilepsy: parental and caregiver perspectives of participation in a compassionate access scheme. BMC health services research. vol 22. issue 1. 2022-02-11. PMID:35144615. |
cannabidiol and refractory epilepsy: parental and caregiver perspectives of participation in a compassionate access scheme. |
2022-02-11 |
2023-08-13 |
Not clear |
| S Harte, Y Singh, S Malone, H Heussler, G Wallac. Cannabidiol and refractory epilepsy: parental and caregiver perspectives of participation in a compassionate access scheme. BMC health services research. vol 22. issue 1. 2022-02-11. PMID:35144615. |
the compassionate access scheme (cas) being delivered through the queensland children's hospital is designed to allow access to an investigational purified cannabidiol oral solution to paediatric patients with severe refractory epilepsy. |
2022-02-11 |
2023-08-13 |
Not clear |
| Christine Prager, Fabienne Kühne, Anna Tietze, Angela M Kaind. Is cannabidiol worth a trial in Rasmussen encephalitis? European journal of paediatric neurology : EJPN : official journal of the European Paediatric Neurology Society. vol 37. 2022-01-30. PMID:35093803. |
we report 3 patients (age 8, 13 and 14 years) with drug-resistant epilepsy due to rasmussen encephalitis treated with cannabidiol in addition to their current antiseizure medication (asm). |
2022-01-30 |
2023-08-13 |
Not clear |
| Renad Abu-Sawwa, Aaron Chase, Olubusola Fowowe, Yong Par. Effects of Epidiolex® (Cannabidiol) on seizure-related emergency department visits and hospital admissions: A retrospective cohort study. Epilepsy & behavior : E&B. vol 127. 2022-01-20. PMID:35051868. |
the aim of this study was to evaluate the potential impact of cannabidiol (cbd) on healthcare resource utilization and determine the effect of cbd on seizure-related emergency departments (ed) and hospital admissions in patients with epilepsy. |
2022-01-20 |
2023-08-13 |
Not clear |
| Offer E Edelstei. Attitudes and beliefs of medicine and social work students about medical cannabis use for epilepsy. Epilepsy & behavior : E&B. vol 127. 2022-01-09. PMID:34999501. |
attitudes and beliefs of medicine and social work students about medical cannabis use for epilepsy. |
2022-01-09 |
2023-08-13 |
human |
| Offer E Edelstei. Attitudes and beliefs of medicine and social work students about medical cannabis use for epilepsy. Epilepsy & behavior : E&B. vol 127. 2022-01-09. PMID:34999501. |
the current study sought: (i) to explore whether health profession students possess formal medical cannabis (mc) education, feel prepared to answer questions about mc, and perceive it as an effective therapy for epilepsy; (ii) to assess students' attitudes and beliefs about mc use; and (iii) to explore the associations between students' background characteristics, mc-related attitudes and beliefs regarding its effectiveness for epilepsy. |
2022-01-09 |
2023-08-13 |
human |
| Offer E Edelstei. Attitudes and beliefs of medicine and social work students about medical cannabis use for epilepsy. Epilepsy & behavior : E&B. vol 127. 2022-01-09. PMID:34999501. |
prior recreational cannabis use [or=1.541] and having friends who recreationally use the substance [or=1.891] were associated with the belief that mc is an effective therapy for epilepsy. |
2022-01-09 |
2023-08-13 |
human |